Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 315Lymphoma 282Leukemia 227Precursor Cell Lymphoblastic Leukemia-Lymphoma 216Lymphoma, Non-Hodgkin 178Leukemia, Lymphocytic, Chronic, B-Cell 177Multiple Myeloma 174Lymphoma, Large B-Cell, Diffuse 174Lymphoma, Follicular 142Leukemia, Myeloid, Acute 136Lymphoma, Mantle-Cell 126Hodgkin Disease 125Burkitt Lymphoma 118Myelodysplastic Syndromes 110Lymphoma, Large-Cell, Immunoblastic 89Lymphoma, B-Cell, Marginal Zone 85Recurrence 67Neoplasms, Plasma Cell 62Leukemia, Myeloid, Chronic-Phase 59Neuroblastoma 56Dendritic Cell Sarcoma, Interdigitating 56Leukemia, Myeloid, Accelerated Phase 55Myeloproliferative Disorders 54Melanoma 54Congenital Abnormalities 48Neoplasms 47Leukemia, Myelomonocytic, Chronic 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Blast Crisis 45Lymphoma, Large-Cell, Anaplastic 44

Interventions

Temozolomide 6Irinotecan 4Carboplatin 3entinostat 2Thiotepa 2Surgical Procedures, Operative 2Radiotherapy, Conformal 2Proton Therapy 2Peripheral Blood Stem Cell Transplantation 2Filgrastim 2Donepezil 2Bevacizumab 2trametinib 1tozuleristide 1temsirolimus 1sonidegib 1ribociclib 1plerixafor 1etoposide phosphate 1carboxyamido-triazole 1adavosertib 1Vorinostat 1Vincristine 1Thalidomide 1Surveys and Questionnaires 1Stem Cell Transplantation 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pinealoma × Cyclophosphamide × Clear all
NCT00867178 2022-01-13

Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System

National Cancer Institute (NCI)

Phase 1 Completed
33 enrolled
CNS

Medulloblastoma, Pinealoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡